Hydrogel-mediated release of basic fibroblast growth factor from a stent-graft accelerates biological fixation with the aortic wall in a porcine model

Journal of Endovascular Therapy

Volumn 14, Issue 6, 2007, Pages 785-793

  Kusanagi, Miho ^a   Matsui, Osamu ^a   Sanada, Junichiro ^a   Ogi, Takahiro ^a   Takamatsu, Shigeyuki ^a   Zhong, Hongshan ^a   Kimura, Yu ^b   Tabata, Yasuhiko ^b  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Aortic wall; Basic fibroblast growth factor; Biological fixation; Controlled release; Hydrogel; Stent graft

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; FIBROBLAST GROWTH FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA GRAFT; AORTA WALL; ARTICLE; CELL PROLIFERATION; HYDROGEL; IMPLANTATION; INTRAVASCULAR ULTRASOUND; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL;

ACTINS; ALLOYS; ANGIOGRAPHY, DIGITAL SUBTRACTION; ANIMALS; AORTA; BIOCOMPATIBLE MATERIALS; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; CARDIOVASCULAR AGENTS; CELL PROLIFERATION; DELAYED-ACTION PREPARATIONS; DRUG-ELUTING STENTS; FIBROBLAST GROWTH FACTOR 2; GELATIN; HYDROGELS; MODELS, ANIMAL; POLYESTERS; PROSTHESIS DESIGN; RECOMBINANT PROTEINS; RESEARCH DESIGN; SWINE; TUNICA INTIMA; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 37049012677     PISSN: 15266028     EISSN: None     Source Type: Journal    
DOI: 10.1583/07-2189.1     Document Type: Article

References (22)

1. Leurs LJ, Bell R, Degrieck Y, et al. Endovascular treatment of thoracic aortic diseases: combined experience from the EUROSTAR and United Kingdom Thoracic Endograft registries. J Vasc Surg. 2004;40:670-680.
2. Doss M, Wood JP, Balzer J, et al. Emergency endovascular interventions for acute thoracic aortic rupture: four-year follow-up. J Thorac Cardiovasc Surg. 2005;129:645-651.
3. Brandt M, Hussel K, Walluscheck KP, et al. Stent-graft repair versus open surgery for the descending aorta: a case-control study. J Endovasc Ther. 2004;11:535-538.
4. Greenhalgh RM, Brown LC, Kwong GP, et al. Comparison of endovascular aneurysm repair with open repair in patients with abdominal aortic aneurysm (EVAR trial 1), 30-day operative mortality results: randomised controlled trial. Lancet. 2004;364:843-848.
5. Prinssen M, Verhoeven EL, Buth J, et al. A randomized trial comparing conventional and endovascular repair of abdominal aortic aneurysms. N Engl J Med. 2004;351:1607-1618.
6. Veith FJ, Baum RA, Ohki T, et al. Nature and significance of endoleaks and endotension: summary of opinions expressed at an international conference. J Vasc Surg. 2002;35:1029-1038.
7. Gilling-Smith G, Brennan J, Harris P, et al. Endotension after endovascular aneurysm repair: definition, classification, and strategies for surveillance and intervention. J Endovasc Surg. 1999;6:305-307.
8. White GH, Yu W, May J, et al. Endoleak as a complication of endoluminal grafting of abdominal aortic aneurysms: classification, incidence, diagnosis, and management. J Endovasc Surg. 1997;4:152-168.
9. Marty B, Leu AJ, Mucciolo A, et al. Biologic fixation of polyester-versus polyurethane-covered stents in a porcine model. J Vasc Interv Radiol. 2002;13:601-607.
10. Szilagyi DE. The problem of healing of endovascular stent grafts in the repair of abdominal aortic aneurysms. J Vasc Surg. 2001;33: 1283-1285.
11. Asai J, Takenaka H, Ichihashi K, et al. Successful treatment of diabetic gangrene with topical application of a mixture of peripheral blood mononuclear cells and basic fibroblast growth factor. J Dermatol. 2006;33:349-352.
12. Akita S, Akino K, Imaizumi T, et al. A basic fibroblast growth factor improved the quality of skin grafting in burn patients. Burns. 2005; 31:855-858.
13. Conklin BS, Wu H, Lin PH, et al. Basic fibroblast growth factor coating and endothelial cell seeding of a decellularized heparin-coated vascular graft. Artif Organs. 2004;28:668-675.
14. Tabata Y, Nagano A, Ikada Y. Biodegradation of hydrogel carrier incorporating fibroblast growth factor. Tissue Eng. 1999;5:127-138.
15. Sanada J, Matsui O, Terayama N, et al. Clinical application of a curved nitinol stent-graft for thoracic aortic aneurysms. J Endovasc Ther. 2003;10:20-28.
16. Tabata Y, Ikada Y. Vascularization effect of basic fibroblast growth factor released from gelatin hydrogels with different biodegradabilities. Biomaterials. 1999;20:2169-2175.
17. Malina M, Brunkwall J, Ivancev K, et al. Endovascular healing is inadequate for fixation of Dacron stent-graft in human aortoiliac vessels. Eur J Vasc Endovasc Surg. 2001;19:5-11.
18. Slavin J. Fibroblast growth factors: at the heart of angiogenesis. Cell Biol Int. 1995;19:431-444.
19. Kearney M, Pieczek A, Haley L, et al. Histopathology of in-stent restenosis in patients with peripheral artery disease. Circulation. 1997;95: 1998-2002.
20. Bashar AH, Kazui T, Terada H, et al. Histological changes in canine aorta 1 year after stent-graft implantation: implications for the long-term stability of device anchoring zones. J Endovasc Ther. 2002;9:320-332.
21. van der Bas JM, Quax PH, van den Berg AC, et al. Ingrowth of aorta vascular cells into basic fibroblast growth factor-impregnated vascular prosthesis material: a porcine and human in vitro study on blood vessel prosthesis healing. J Vasc Surg. 2002;36:1237-1247.
22. van der Bas JM, Quax PH, van den Berg AC, et al. Ingrowth of aorta wall into stent grafts impregnated with basic fibroblast growth factor: a porcine in vivo study of blood vessel prosthesis healing. J Vasc Surg. 2004;39:850-858.